Tenon Medical (NASDAQ:TNON) & Axonics (NASDAQ:AXNX) Critical Comparison

Tenon Medical (NASDAQ:TNON) and Axonics (NASDAQ:AXNX) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, dividends, profitability, valuation, analyst recommendations and institutional ownership.

Analyst Ratings

This is a summary of current recommendations for Tenon Medical and Axonics, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tenon Medical	0	0	1	0	3.00
Axonics	0	8	2	0	2.20

Tenon Medical presently has a consensus price target of $3.00, indicating a potential upside of 370.29%. Axonics has a consensus price target of $69.57, indicating a potential upside of 1.58%. Given Tenon Medical’s stronger consensus rating and higher possible upside, equities analysts plainly believe Tenon Medical is more favorable than Axonics.

Insider and Institutional Ownership

22.7% of Tenon Medical shares are held by institutional investors. Comparatively, 99.5% of Axonics shares are held by institutional investors. 4.7% of Tenon Medical shares are held by company insiders. Comparatively, 1.9% of Axonics shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Profitability

This table compares Tenon Medical and Axonics’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Tenon Medical	-445.77%	-1,267.31%	-181.71%
Axonics	-4.12%	-2.58%	-2.32%

Risk and Volatility

Tenon Medical has a beta of 2.18, indicating that its stock price is 118% more volatile than the S&P 500. Comparatively, Axonics has a beta of 0.83, indicating that its stock price is 17% less volatile than the S&P 500.

Valuation & Earnings

This table compares Tenon Medical and Axonics’ gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tenon Medical	$2.93 million	0.82	-$15.58 million	($6.69)	-0.10
Axonics	$366.38 million	9.54	-$6.09 million	($0.32)	-214.03

Axonics has higher revenue and earnings than Tenon Medical. Axonics is trading at a lower price-to-earnings ratio than Tenon Medical, indicating that it is currently the more affordable of the two stocks.

Summary

Axonics beats Tenon Medical on 9 of the 14 factors compared between the two stocks.

About Tenon Medical

Tenon Medical, Inc., a medical device company, engages in the development of surgical implant systems to treat severe lower back pain in the United States and Puerto Rico. The company offers CATAMARAN SI-Joint Fusion System to fuse sacroiliac joints (SI-Joints) to treat SI-Joint dysfunction that often causes severe lower back pain; and features fixation device that passes through the axial and sagittal planes of the ilium and sacrum, as well as transfixes the SI joints. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.

About Axonics

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction. Its sacral neuromodulation (SNM) systems are used to treat patients with overactive bladder (OAB), including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence (FI) and non-obstructive urinary retention (UR); and rechargeable (R20) and recharge-free (F15) implantable SNM systems that delivers mild electrical pulses to the targeted sacral nerve to restore normal communication to and from the brain to reduce the symptoms of OAB, UR, and FI. The company also offers Bulkamid, a urethral bulking agent to treat female stress urinary incontinence. It sells its products through a direct sales force and distributors in the United States, the United Kingdom, Germany, the Netherlands, Nordic countries, and internationally. The company was formerly known as Axonics Modulation Technologies, Inc. and changed its name to Axonics, Inc. in March 2021. Axonics, Inc. was incorporated in 2012 and is based in Irvine, California.